The U.S Department of Health and Human Services (HHS) has issued a warning concerning potential cyber attacks, including email bombing and credential harvesting on telehealth platforms. This emphasizes the need for professional training and consultation to protect sensitive data.
Startup OMass Secures $310M to Advance Drug for Rare Endocrine Disorder
OMass’s molecule is vying to become an alternative to a Neurocrine Biosciences drug that is currently the only FDA-approved therapy for congenital adrenal hyperplasia. But
